At the news
? NEUTRALIMPACT 2/10 144 filed Nov 3, 2026 at 16:26 ET
Christine Ring, an officer of Nurix Therapeutics, filed a Form 144 notice of intent to sell 6,113 shares of common stock, with an estimated aggregate market value of approximately $157,104. The filing also discloses four prior 10b5-1 plan sales executed between September and November 2026, totaling 22,175 shares. This is a routine insider sale under a pre-arranged trading plan, representing a small fraction of the company's $3.0B market cap.
- Christine Ring, an officer, filed Form 144 to sell 6,113 shares of common stock.
- Estimated aggregate market value of the proposed sale is $157,104.10.
- The filing also reports four prior 10b5-1 plan sales from September to November 2026 totaling 22,175 shares.
- The proposed sale represents about 0.005% of the company's $3.0B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access